4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063804
President and CEO gave up 833 shares (to pay taxes)
- President and CEO acquired 2,925 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-18 | Exercise or conversion : show line 1 in the form | +2,925 | 910,957 | D | ||
| 2018-12-18 | Shares withheld for taxes : show line 2 in the form | −833 | $6.30 | $5,248 | 910,124 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-12-18 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −2,925 | 2,925 | D |
Loading xslF345X03/doc4.xml…